Published in Planta on November 03, 2010
Isolation and characterization of ripening related pectin methylesterase inhibitor gene from banana fruit. Physiol Mol Biol Plants (2012) 0.77
Three pectin methyl esterase inhibitors protect cell wall integrity for immunity to Botrytis. Plant Physiol (2017) 0.75
Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol (1981) 14.45
Toward a systems approach to understanding plant cell walls. Science (2004) 5.60
Pectin methylesterases: cell wall enzymes with important roles in plant physiology. Trends Plant Sci (2001) 3.60
Pectin esterification is spatially regulated both within cell walls and between developing tissues of root apices. Planta (1990) 3.03
New insights into pectin methylesterase structure and function. Trends Plant Sci (2007) 2.64
Cell Wall Dissolution in Ripening Kiwifruit (Actinidia deliciosa) : Solubilization of the Pectic Polymers. Plant Physiol (1992) 2.27
Pectin methylesterases and pectin dynamics in pollen tubes. Plant Cell (2005) 1.87
Structural basis for the interaction between pectin methylesterase and a specific inhibitor protein. Plant Cell (2005) 1.49
Pectin methylesterase inhibitor. Biochim Biophys Acta (2004) 1.34
Structural insights into the target specificity of plant invertase and pectin methylesterase inhibitory proteins. Plant Cell (2004) 1.33
Pepper pectin methylesterase inhibitor protein CaPMEI1 is required for antifungal activity, basal disease resistance and abiotic stress tolerance. Planta (2008) 1.26
The N-terminal pro region mediates retention of unprocessed type-I PME in the Golgi apparatus. Plant J (2009) 1.26
A glycoprotein inhibitor of pectin methylesterase in kiwi fruit (Actinidia chinensis). Eur J Biochem (1990) 1.26
Pectin Modification in Cell Walls of Ripening Tomatoes Occurs in Distinct Domains. Plant Physiol (1997) 1.19
Identification of pollen-expressed pectin methylesterase inhibitors in Arabidopsis. FEBS Lett (2003) 1.19
Tomato pectin methylesterase: modeling, fluorescence, and inhibitor interaction studies-comparison with the bacterial (Erwinia chrysanthemi) enzyme. Proteins (2003) 1.05
Kiwi protein inhibitor of pectin methylesterase amino-acid sequence and structural importance of two disulfide bridges. Eur J Biochem (2000) 1.02
A glycoprotein inhibitor of pectin methylesterase in kiwi fruit. Purification by affinity chromatography and evidence of a ripening-related precursor. Eur J Biochem (1995) 1.01
Proteomics in Drosophila melanogaster: first 2D database of larval hemolymph proteins. Biochem Biophys Res Commun (2003) 0.95
Reticulate evolution in kiwifruit (Actinidia, Actinidiaceae) identified by comparing their maternal and paternal phylogenies. Am J Bot (2004) 0.90
Pectin methyl esterase from orange fruit: characterization and localization by in-situ hybridization and immunohistochemistry. Planta (1998) 0.84
Localization of Cell Wall Polysaccharides during Kiwifruit (Actinidia deliciosa) Ripening. Int J Plant Sci (1999) 0.81
Modulation of TAFI function through different pathways--implications for the development of TAFI inhibitors. J Thromb Haemost (2005) 0.81
A pectin-methylesterase-inhibitor-based molecular probe for in situ detection of plant pectin methylesterase activity. J Agric Food Chem (2010) 0.79
Effect of intrinsic and extrinsic factors on the interaction of plant pectin methylesterase and its proteinaceous inhibitor from kiwi fruit. J Agric Food Chem (2004) 0.76
Development and evaluation of monoclonal antibodies as probes to assess the differences between two tomato pectin methylesterase isoenzymes. J Immunol Methods (2009) 0.75
Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trial. Gut (2011) 2.58
The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J (2002) 1.70
Antibody response to infliximab and its impact on pharmacokinetics can be transient. Am J Gastroenterol (2013) 1.61
Biochemical importance of glycosylation in thrombin activatable fibrinolysis inhibitor. Circ Res (2007) 1.48
Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene (2004) 1.33
Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulation (2002) 1.22
Pectin methylesterase and its proteinaceous inhibitor: a review. Carbohydr Res (2010) 1.19
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo. Thromb Res (2012) 1.17
Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin. Semin Thromb Hemost (2013) 1.11
Plasminogen activator inhibitor-1. Curr Med Chem (2004) 1.10
Evidence for a pre-latent form of the serpin plasminogen activator inhibitor-1 with a detached beta-strand 1C. J Biol Chem (2006) 1.04
Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol Endocrinol Metab (2005) 1.01
Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials. Invest Ophthalmol Vis Sci (2003) 0.98
The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors. Thromb Haemost (2004) 0.97
Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation. Arterioscler Thromb Vasc Biol (2007) 0.94
Improved functionalization of oleic acid-coated iron oxide nanoparticles for biomedical applications. J Nanopart Res (2012) 0.94
Biosimilar monoclonal antibodies: a science-based regulatory challenge. Expert Opin Biol Ther (2013) 0.91
Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling. Cancer Cell (2013) 0.91
Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives. Curr Gastroenterol Rep (2014) 0.90
Heat-induced changes in the susceptibility of egg white proteins to enzymatic hydrolysis: a kinetic study. J Agric Food Chem (2003) 0.89
Development of ELISAs measuring the extent of TAFI activation. Arterioscler Thromb Vasc Biol (2005) 0.88
Stiffness of Ca(2+)-pectin gels: combined effects of degree and pattern of methylesterification for various Ca(2+) concentrations. Carbohydr Res (2011) 0.88
Mechanism and related kinetics of 5-methyltetrahydrofolic acid degradation during combined high hydrostatic pressure-thermal treatments. J Agric Food Chem (2009) 0.87
Additivity in effects of vitronectin and monoclonal antibodies against alpha-helix F of plasminogen activator inhibitor-1 on its reactions with target proteinases. J Biol Chem (2004) 0.87
Characterization of a novel intracellular endopeptidase of the alpha/beta hydrolase family from Streptomyces coelicolor A3(2). J Bacteriol (2003) 0.86
Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study. Ann Intern Med (2015) 0.86
Biochemical importance of glycosylation of plasminogen activator inhibitor-1. Thromb Haemost (2003) 0.86
Mechanisms of conversion of plasminogen activator inhibitor 1 from a suicide inhibitor to a substrate by monoclonal antibodies. J Biol Chem (2002) 0.86
Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse. Inflamm Bowel Dis (2015) 0.86
Particle size reduction leading to cell wall rupture is more important for the β-carotene bioaccessibility of raw compared to thermally processed carrots. J Agric Food Chem (2010) 0.85
Thermal stability of L-ascorbic acid and ascorbic acid oxidase in broccoli (Brassica oleracea var. italica). J Food Sci (2010) 0.85
Modulation of serpin reaction through stabilization of transient intermediate by ligands bound to alpha-helix F. J Biol Chem (2007) 0.85
An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases. Inflamm Bowel Dis (2015) 0.85
Lycopene degradation and isomerization kinetics during thermal processing of an olive oil/tomato emulsion. J Agric Food Chem (2010) 0.85
Maximal PAI-1 inhibition in vivo requires neutralizing antibodies that recognize and inhibit glycosylated PAI-1. Thromb Res (2011) 0.84
Beta-carotene isomerization kinetics during thermal treatments of carrot puree. J Agric Food Chem (2010) 0.84
A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state. Mol Pharmacol (2008) 0.84
Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective study. Inflamm Bowel Dis (2015) 0.84
Remarkable stabilization of plasminogen activator inhibitor 1 in a "molecular sandwich" complex. Biochemistry (2013) 0.84
Comparative study of the cell wall composition of broccoli, carrot, and tomato: structural characterization of the extractable pectins and hemicelluloses. Carbohydr Res (2011) 0.84
Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab Assays. Ther Drug Monit (2015) 0.84
Characterization and comparative evaluation of a novel PAI-1 inhibitor. Thromb Haemost (2002) 0.83
Activation of the zymogen to urokinase-type plasminogen activator is associated with increased interdomain flexibility. J Mol Biol (2011) 0.83
His374 of wheat endoxylanase inhibitor TAXI-I stabilizes complex formation with glycoside hydrolase family 11 endoxylanases. FEBS J (2005) 0.83
Pressure and temperature stability of 5-methyltetrahydrofolic acid: a kinetic study. J Agric Food Chem (2005) 0.83
Enhancement of endogenous fibrinolysis does not reduce local fibrin deposition, but modulates inflammation upon intestinal ischemia and reperfusion. Thromb Haemost (2004) 0.83
Redirection of the reaction between activated protein C and a serpin to the substrate pathway. Thromb Res (2007) 0.83
Changes in sulfhydryl content of egg white proteins due to heat and pressure treatment. J Agric Food Chem (2005) 0.82
Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor. Circulation (2011) 0.82
Purification and thermal and high-pressure inactivation of pectinmethylesterase isoenzymes from tomatoes (Lycopersicon esculentum): a novel pressure labile isoenzyme. J Agric Food Chem (2007) 0.81
Generation of a stable activated thrombin activable fibrinolysis inhibitor variant. J Biol Chem (2006) 0.81
Fibrinogen contains cryptic PAI-1 binding sites that are exposed on binding to solid surfaces or limited proteolysis. Arterioscler Thromb Vasc Biol (2005) 0.81
Value of drug level testing and antibody assays in optimising biological therapy. Frontline Gastroenterol (2012) 0.81
Activity and process stability of purified green pepper (Capsicum annuum) pectin methylesterase. J Agric Food Chem (2004) 0.81
High thrombin activatable fibrinolysis inhibitor levels are associated with an increased risk of premature peripheral arterial disease. Thromb Res (2010) 0.81
Novel targeted approach to better understand how natural structural barriers govern carotenoid in vitro bioaccessibility in vegetable-based systems. Food Chem (2013) 0.80
Mode of de-esterification of alkaline and acidic pectin methyl esterases at different pH conditions. J Agric Food Chem (2006) 0.80
Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol (2011) 0.80
Effect of mild-heat and high-pressure processing on banana pectin methylesterase: a kinetic study. J Agric Food Chem (2003) 0.80
Thrombin activatable fibrinolysis inhibitor: a putative target to enhance fibrinolysis. Semin Thromb Hemost (2013) 0.80
Elucidation of the epitope of a latency-inducing antibody: identification of a new molecular target for PAI-1 inhibition. Thromb Haemost (2003) 0.80
Development of a universal anti-adalimumab antibody standard for interlaboratory harmonization. Ther Drug Monit (2014) 0.80
The kinetics of β-elimination of cystine and the formation of lanthionine in gliadin. J Agric Food Chem (2010) 0.80
The conversion of active to latent plasminogen activator inhibitor-1 is an energetically silent event. Biophys J (2005) 0.79
Kinetics of alkaline phosphatase and lactoperoxidase inactivation, and of beta-lactoglobulin denaturation in milk with different fat content. J Dairy Res (2002) 0.79
The story of the serpin plasminogen activator inhibitor 1: is there any need for another mutant? Thromb Haemost (2004) 0.79
Development of a genotype 325-specific proCPU/TAFI ELISA. Arterioscler Thromb Vasc Biol (2003) 0.79
Use of mouse models to study plasminogen activator inhibitor-1. Methods Enzymol (2011) 0.79
The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex. J Biol Chem (2008) 0.79
Influence of reducing carbohydrates on (6S)-5-methyltetrahydrofolic acid degradation during thermal treatments. J Agric Food Chem (2010) 0.79
Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits. Am J Respir Cell Mol Biol (2015) 0.79
Nebulized fibrinolytic agents improve pulmonary fibrinolysis but not inflammation in rat models of direct and indirect acute lung injury. PLoS One (2013) 0.79
A pectin-methylesterase-inhibitor-based molecular probe for in situ detection of plant pectin methylesterase activity. J Agric Food Chem (2010) 0.79
Immobilization of the distal hinge in the labile serpin plasminogen activator inhibitor 1: identification of a transition state with distinct conformational and functional properties. J Biol Chem (2003) 0.79
Tryptophan properties in fluorescence and functional stability of plasminogen activator inhibitor 1. Biophys J (2003) 0.79